ReviewCancers2022
Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in
Rinat Bernstein-Molho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it